AN2 Therapeutics is a global health biopharmaceutical company focused on bringing the power of modern biomedical and drug development expertise to create transformational medicines for patients suffering from infectious diseases. The founding team is uniquely experienced in leveraging strategic partnerships and non-dilutive funding to support global public health programs.
| Date | Amount | Type | Investors | Valuation |
|---|---|---|---|---|
| 11/21/19 | $12,000,000 | Series A |
Adjuvant Capital BioRock Ventures Brii Biosciences Mountain Group Partners  | undisclosed |
